Fluvoxamine Maleate in the Treatment of Obsessive-Compulsive Disorder: A Post-marketing Clinical Study in Children and Adolescents

NCT00352768 · clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
20
Enrollment
INDUSTRY
Sponsor class

Stopped This study was prematurely terminated (26 June 2009) due to slow recruitment

Conditions

Interventions

Sponsor

Solvay Pharmaceuticals